PMGC Holdings unit reports Phase III drug discovery results with Yuva
Go back to PMGC Holdings unit reports Phase III drug discovery results with Yuva| (NASDAQ: ELAB) | Delayed: 0.95 -0.07 (6.86%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.02 | 52 Week High | $ | |||
| Open | $1.00 | 52 Week Low | $ | |||
| Day High | $1.00 | P/E | N/A | |||
| Day Low | $0.90 | EPS | $ | |||
| Volume | 729,873 | |||||
